Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,239,626
  • Shares Outstanding, K 75,463
  • Annual Sales, $ 0 K
  • Annual Income, $ -182,390 K
  • 60-Month Beta 1.19
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.05
Trade XENE with:

Options Overview Details

View History
  • Implied Volatility 51.83% ( -4.44%)
  • Historical Volatility 35.83%
  • IV Percentile 34%
  • IV Rank 14.61%
  • IV High 142.33% on 11/24/23
  • IV Low 36.35% on 09/15/23
  • Put/Call Vol Ratio 0.09
  • Today's Volume 25
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 2,982
  • Open Int (30-Day) 4,280

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.69
  • Number of Estimates 8
  • High Estimate -0.63
  • Low Estimate -0.77
  • Prior Year -0.63
  • Growth Rate Est. (year over year) -9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.85 +9.37%
on 04/25/24
44.37 -4.23%
on 05/06/24
-0.54 (-1.25%)
since 04/09/24
3-Month
38.85 +9.37%
on 04/25/24
50.99 -16.67%
on 03/01/24
-7.55 (-15.09%)
since 02/09/24
52-Week
27.99 +51.83%
on 11/13/23
50.99 -16.67%
on 03/01/24
-1.05 (-2.41%)
since 05/09/23

Most Recent Stories

More News
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 42.49 (-1.02%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 42.49 (-1.02%)
Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise, Monday, 11/27/2023

Stocks that traded heavily or had substantial price changes on Monday: Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise

CRNC : 6.28 (-34.31%)
SHOP.TO : 85.39 (-0.89%)
NEM : 42.84 (+3.13%)
XENE : 42.49 (-1.02%)
FCX : 51.08 (+2.24%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 42.49 (-1.02%)
Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Pharmaceuticals: Q2 Earnings Snapshot

XENE : 42.49 (-1.02%)
Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Lags Revenue Estimates

Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -1.61% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

XENE : 42.49 (-1.02%)
MGTX : 5.10 (-0.78%)
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 42.49 (-1.02%)
Earnings Preview: Fortress Biotech (FBIO) Q1 Earnings Expected to Decline

Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FBIO : 1.7100 (-2.29%)
XENE : 42.49 (-1.02%)
Sutro Biopharma, Inc. (STRO) Soars 11.3%: Is Further Upside Left in the Stock?

Sutro Biopharma, Inc. (STRO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...

STRO : 4.35 (+1.64%)
XENE : 42.49 (-1.02%)
Incyte (INCY) Q1 Earnings and Revenues Miss Estimates

Incyte (INCY) delivered earnings and revenue surprises of -56.47% and 7.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

INCY : 53.50 (-0.02%)
XENE : 42.49 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan...

See More

Key Turning Points

3rd Resistance Point 43.71
2nd Resistance Point 43.36
1st Resistance Point 42.93
Last Price 42.49
1st Support Level 42.15
2nd Support Level 41.80
3rd Support Level 41.37

See More

52-Week High 50.99
Last Price 42.49
Fibonacci 61.8% 42.20
Fibonacci 50% 39.49
Fibonacci 38.2% 36.77
52-Week Low 27.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar